AKT3 and ovarian carcinoma: In addition, Chen et al. have reported that miR-489 modulates chemosensitivity in human breast cancer cells [46], and upregulation of miR-489 restores the cisplatin chemosensitivity in ovarian cancer cells via directly targeting Akt3 for degradation [47].